RE:Great more green days Rosenberg is still trying to link FSD with a successful company just because they share a parking lot.....psst Rosenberg.....it doesn't work that way......you still keep posting what ifs and maybe with no facts to make an actual relevant statement......just assumptions with no substance...."they are most likely screening for people right now"....based on what....a want ad for researchers.....all we know for certain is that FSD bought Lucid which didn't include a team of researchers to do the work....just some high priced execs who are now dipping into the investor trough....how about you answer these questions......what is Lucid's track record for hiring, treating, and retaining research employees?....why was a research team not included in the agrrement for purchase?.....did Lucid have a research team available on staff and if not why?.....those are the questions tat need answering Rosennberg.....those are the answers investors such as myself want to know......
DavidRosenberg wrote: Still a long way to go but hopefully markets realize that FSD Pharma has something very valuable with Lucid and UHN Network. $TRIL was also part of UHN Network conducting their own trials before it was boughtout by pfizer. That is factual information. It does not mean Lucid will be the same. Lucid and FSD Pharma will have to prove their worth but the fact that there is a credibile institution with real scientists doing work.
Lucid is on a hiring spree hiring the people needed to conduct all these things they are most likely screening for people right now.
Covar Pharmaceuticals will be creating the drugs needed to conduct the trials, for now it's sitting in the lab the secret ingredients that lucid has for their FSD Lucid Drug pipelines.
Pfizer to buy Canadian drug developer Trillium Therapeutics for $2.2B | CBC News